Initial ELSO Guidance Document ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure
The Extracorporeal Life Support Organization (ELSO) and all of the ELSO worldwide chapters have prepared this document to describe when and how to use extracorporeal membrane oxygenation (ECMO) in COVID-19 patients during this pandemic.
Coronaviruses and the Cardiovascular System: Acute and Long-Term Implications
The present COVID-19 outbreak emphasizes the need for greater awareness of the immediate and long-term cardiovascular implications of viral infection and the significant gaps in knowledge that future research will need to address.
ECMO for COVID19 in Japan
Current situation of ECMO use in Japan for COVID-19 associated ARDS: second ELSO webinar focused on the use of ECLS during the SARS-CoV-2 pandemics, run on March 30th.
ECMO in COVID19: The Power of Connection
The power of connection: at a time when social distancing is a universal necessity, connecting as a healthcare community has never been so vitally important to keeping our patients & colleagues safe.
The Use of Extracorporeal Membrane Oxygenation in Human Immunodeficiency Virus–Positive Patients: a Review of a Multicenter Database
Survival among patients with human immunodeficiency virus infection who receive extracorporeal membrane oxygenation was less than 40%.
Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort
Ultraprotective lung ventilation on ECMO was largely adopted across medium– to high–case volume ECMO centers. In contrast with previous observations, mechanical ventilation settings during ECMO did not impact patients’ prognosis in this context.
Extracorporeal Membrane Oxygenation Support for Postcardiotomy Cardiogenic Shock in Adult Patients: Predictors of In-Hospital Mortality and Failure to be Weaned from Extracorporeal Membrane Oxygenation
Our data suggest a reevaluation of therapeutic strategies after 60 h and again after 130 h of ECMO support.
Anticoagulation in Neonatal ECMO: An Enigma Despite a Lot of Effort!
This review provides an overview of hemostatic alterations, anticoagulation, monitoring and management, novel anticoagulant use, and circuit modifications for neonatal ECMO. Future considerations are also presented.
Venoarterial Extracorporeal Membrane Oxygenation in Sickle Cell Disease for Urgent Cardiac Surgery
This highlights that SCD should not be a counterindication to VA-ECMO, pending multidisciplinary management.
Methylprednisolone May be Associated with Improved Lung Compliance in Acute Respiratory Distress Syndrome Patients on Veno-Venous Extracorporeal Membrane Oxygenation
Further studies are required to identify appropriate patient selection for methylprednisolone use in patients on veno-venous extracorporeal membrane oxygenation.
Impact of Delayed Systemic Heparinization on Postoperative Bleeding and Thromboembolism During Post-Cardiotomy Extracorporeal Membrane Oxygenation in Neonates
In this retrospective analysis, the results of delayed systemic heparinization in neonatal post-cardiotomy extracorporeal membrane oxygenation could lead one to conclude that this routine is safe and favorable with low risk for thromboembolic events, reduced postoperative hemorrhage, and reduced blood product utilization.
Preparing for the Most Critically Ill Patients With COVID-19: The Potential Role of Extracorporeal Membrane Oxygenation
The WHO interim guidelines made general recommendations for treatment of ARDS in this setting, including that consideration be given to referring patients with refractory hypoxemia to expert centers capable of providing extracorporeal membrane oxygenation (ECMO).